Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,957.88 +1,531.39 (+2.34%) CMC Crypto 200
1,369.64 -4.20 (-0.31%)
Sana Biotechnology, Inc. (SANA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.93B |
| Enterprise value | 1.73B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 5.15 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.08 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.62 |
| 52-week change 3 | 15.94% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 12.00 |
| 52-week low 3 | 2.74 |
| 50-day moving average 3 | 8.97 |
| 200-day moving average 3 | 6.03 |
Share statistics
| Avg vol (3-month) 3 | 1.91M |
| Avg vol (10-day) 3 | 2.14M |
| Shares outstanding 5 | 221.5M |
| Implied shares outstanding 6 | 240.16M |
| Float 8 | 129.01M |
| % held by insiders 1 | 8.63% |
| % held by institutions 1 | 89.97% |
| Shares short (30 Apr 2024) 4 | 25.65M |
| Short ratio (30 Apr 2024) 4 | 17.04 |
| Short % of float (30 Apr 2024) 4 | 24.18% |
| Short % of shares outstanding (30 Apr 2024) 4 | 11.59% |
| Shares short (prior month 28 Mar 2024) 4 | 26.13M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -30.95% |
| Return on equity (ttm) | -76.82% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -329.69M |
| Net income avi to common (ttm) | -308.61M |
| Diluted EPS (ttm) | -1.52 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 311.08M |
| Total cash per share (mrq) | 1.4 |
| Total debt (mrq) | 106.09M |
| Total debt/equity (mrq) | 28.28% |
| Current ratio (mrq) | 6.07 |
| Book value per share (mrq) | 1.70 |
Cash flow statement
| Operating cash flow (ttm) | -239.94M |
| Levered free cash flow (ttm) | -234.63M |
© 2024 Yahoo. All rights reserved.